Found: 37
Select item for more details and to access through your institution.
The Increasing role of health economics in the HTA of COVID19-vaccines.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 13, doi. 10.33320/maced.pharm.bull.2022.68.03.003
- By:
- Publication type:
- Article
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 3, p. 481, doi. 10.1007/s40121-023-00903-0
- By:
- Publication type:
- Article
An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 8, p. 2135, doi. 10.1007/s40121-023-00851-9
- By:
- Publication type:
- Article
Critical Reflections on Reimbursement and Access of Advanced Therapies.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.771966
- By:
- Publication type:
- Article
Cost-Effectiveness of Test-and-Treat Strategies to Reduce the Antibiotic Prescription Rate for Acute Febrile Illness in Primary Healthcare Clinics in Africa.
- Published in:
- Applied Health Economics & Health Policy, 2024, v. 22, n. 5, p. 701, doi. 10.1007/s40258-024-00889-x
- By:
- Publication type:
- Article
Investing in the Prevention of Communicable Disease Outbreaks: Fiscal Health Modelling—The Tool of Choice for Assessing Public Finance Sustainability.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 823, doi. 10.3390/vaccines11040823
- By:
- Publication type:
- Article
Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost.
- Published in:
- Vaccines, 2021, v. 9, n. 2, p. 144, doi. 10.3390/vaccines9020144
- By:
- Publication type:
- Article
Impaired health-related quality of life due to elevated risk of developing diabetes: A cross-sectional study in Indonesia.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0295934
- By:
- Publication type:
- Article
Rationale and development of an e-health application to deliver patient-centered care during treatment for recently diagnosed multiple myeloma patients: pilot study of the MM E-coach.
- Published in:
- Pilot & Feasibility Studies, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40814-023-01307-0
- By:
- Publication type:
- Article
Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 9, p. 1557, doi. 10.1007/s10198-024-01683-1
- By:
- Publication type:
- Article
Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 6, p. 991, doi. 10.1007/s10198-021-01303-2
- By:
- Publication type:
- Article
A novel method for predicting the budget impact of innovative medicines: validation study for oncolytics.
- Published in:
- European Journal of Health Economics, 2020, v. 21, n. 6, p. 845, doi. 10.1007/s10198-020-01176-x
- By:
- Publication type:
- Article
Accuracy of budget impact estimations and impact on patient access: a hepatitis C case study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands.
- Published in:
- Journal of Market Access & Health Policy, 2024, v. 12, n. 3, p. 181, doi. 10.3390/jmahp12030015
- By:
- Publication type:
- Article
Budget and health impact of switching eligible patients with atrial fibrillation to lower-dose dabigatran.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2247719
- By:
- Publication type:
- Article
Affordability of oncology drugs: accuracy of budget impact estimations.
- Published in:
- Journal of Market Access & Health Policy, 2020, v. 8, n. 1, p. 1, doi. 10.1080/20016689.2019.1697558
- By:
- Publication type:
- Article
OP39 The Real-Option Rate Of Return Approach To Inform The Pricing Of Medicines.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, p. S16, doi. 10.1017/S0266462322000964
- By:
- Publication type:
- Article
PP83 A Conceptual Decision-Making Framework For Pharmaceutical Innovations.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, n. 5, p. 723, doi. 10.1111/j.1365-2125.2008.03097.x
- By:
- Publication type:
- Article
The PID Odyssey 2030: outlooks, unmet needs, hurdles, and opportunities -- proceedings from the IPOPI global multi-stakeholders' summit (June 2022).
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1245718
- By:
- Publication type:
- Article
The association of albuminuria and high-sensitivity C-reactive protein with the efficacy of HMG-coenzyme A reductase inhibitors for cardiovascular event prevention.
- Published in:
- European Journal of Preventive Cardiology, 2016, v. 23, n. 7, p. 847, doi. 10.1177/2047487315604310
- By:
- Publication type:
- Article
Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes: A Systematic Review on Content and Adherence to Guidelines.
- Published in:
- PharmacoEconomics, 2008, v. 26, n. 7, p. 569, doi. 10.2165/00019053-200826070-00005
- By:
- Publication type:
- Article
Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the Netherlands: A Comparative Analysis Using Clinical Trial and Drug Utilization Data.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 1, p. 49, doi. 10.2165/11319570-000000000-00000
- By:
- Publication type:
- Article
Information Technology Ambidexterity-Driven Patient Agility, Patient Service- and Market Performance: A Variance and fsQCA Approach.
- Published in:
- Sustainability (2071-1050), 2022, v. 14, n. 7, p. 4371, doi. 10.3390/su14074371
- By:
- Publication type:
- Article
Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0146262
- By:
- Publication type:
- Article
Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature.
- Published in:
- Drug Development Research, 2010, v. 71, n. 8, p. 492, doi. 10.1002/ddr.20424
- By:
- Publication type:
- Article
Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0269853
- By:
- Publication type:
- Article
Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria.
- Published in:
- Nephrology Dialysis Transplantation, 2008, v. 23, n. 4, p. 1103
- By:
- Publication type:
- Article
Psychometric properties of kidney disease quality of life-36 (KDQOL-36) in dialysis patients in Indonesia.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 1, p. 247, doi. 10.1007/s11136-022-03236-6
- By:
- Publication type:
- Article
Charting a course for global progress in PIDs by 2030 — proceedings from the IPOPI global multi-stakeholders’ summit (September 2023).
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1430678
- By:
- Publication type:
- Article
Charting a course for global progress in PIDs by 2030 — proceedings from the IPOPI global multi-stakeholders’ summit (September 2023).
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1430678
- By:
- Publication type:
- Article
Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson's Disease in The Netherlands.
- Published in:
- Drugs & Aging, 2014, v. 31, n. 3, p. 193, doi. 10.1007/s40266-013-0150-4
- By:
- Publication type:
- Article
Reply to Anglemyer et al.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Response: Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Cost-Effectiveness Analysis of Spending on Research and Development to Address the Needs for Innovative Therapeutic Products in Indonesia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Increasing the information provided by probabilistic sensitivity analysis: The relative density plot.
- Published in:
- Cost Effectiveness & Resource Allocation, 2020, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12962-020-00251-7
- By:
- Publication type:
- Article